Trump tariffs would increase costs for almost every biopharma company, survey claims
The Trump administration’s threatened tariffs on Europe would be painful for the biotech industry, according to data from a survey conducted by the industry’s main …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
